Study of calcitonin prescriptions: An estimate of the expenditure due to inadequate use;Estudio de las prescripciones de calcitonina: Estimacion del gasto por prescripcion inadecuada

Medicina Clinica

Volumn 110, Issue 11, 1998, Pages 411-415

  Kanterewicz, Eduardo ^a,c   Iruela, Antonio ^b   Pladevall, Manel ^c   Serrarols, Marta ^b   Pañella, Domingo ^a   Brugués, Joan ^a   Díez, Adolfo ^d  

^a Institut de Recerca   (Spain)

^b CAP El Remei de Vic   (Spain)

^c HOSPITAL GENERAL DE VIC   (Spain)

^d HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN;

ADULT; AGED; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; DRUG COST; FEMALE; HUMAN; LOW BACK PAIN; OSTEOPOROSIS; PRESCRIPTION; SPINE RADIOGRAPHY; VERTEBRA FRACTURE;

ADULT; AGED; AGED, 80 AND OVER; CALCITONIN; FEMALE; HEALTH EXPENDITURES; HEALTH SERVICES MISUSE; HUMANS; MIDDLE AGED; OSTEOPOROSIS; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; SPAIN;

EID: 0032574602     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Cooper C. Epidemiology and public health impact of osteoporosis. Baillière's Clin Rheumatol 1993; 7: 459-476.
2. Schapira D, Schapira S. Osteoporosis: the evolution of a scientific term. Osteoporos Int 1992; 2: 164-167.
3. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltev N. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 1.137-1.141.
4. Cormier C, Epidemiology, diagnosis and treatment of osteoporosis. Curr Opin Rheumatol 1994; 6: 329-335.
5. Cooper C, Kanis JA, Compston J. How to assess drug efficacy in osteoporosis. Lancet 1995; 345: 743-744.
6. Copp DH. Calcitonin: discovery, development and clinical applications. Clin Invest Med 1994; 17: 268-277
7. Yerro Prieto I, Díaz de Torres P, Iñesta A. Calcitonina: su utilización en España a través de recetas de la Seguridad Social. Inf Ter Sec Soc 1990; 14: 37-44.
8. Sampietro-Colom L. La calcitonina en el tractament de l'osteoporosi idiopàtica. Barcelona: Agènda d'Avaluació de Tecnologia Mèdica, 1994. Departament de Sanitat i Seguretat Social; informe n.o 2/95.
9. Nasal salmon calcitonin in osteoporosis [editorial]. Calcif Tissue Int 1994; 55: 79-81.
10. Reginster JY, Meurmans L, Deroisy R, Jupsin Y, Biquet Y, Albert A et al. A 5-years controlled randomized study of postmenopausal trabecular bone loss with nasal salmon calcitonin and calcium. Eur J Clin Invest 1994; 24: 565-569.
11. Overgaard K, Hansen MA, Jensen SB, Christiansen C. Effect of calcitonin given intranasally on bone mass and fractures rates in established osteoporosis. Br Med J 1992; 305: 556-561.
12. Rico H, Hernández ER, Revilla M, Gómez-Castresana F. Salmon calcìtonìn reduces vertebral fracture rate in postmenopausal crush fracture syndrome. Bone Min 1992; 16: 131-138.
13. Bannwarth B, Schaeverbeke T, Dehais J. Calcitonines et ostéoporose: mythes et réalités. Rev Rhum 1995; 52: 3-6.
14. Burckhardt P, Burnand B. The effect of treatment with calcitonin on vertebral fracture rate in osteoporosis. Osteopor Int 1993; 3: 24-30.
15. Magrini N, Vaccheri A, Montanaro N. The Italian way of osteoporosis Lancet 1992; 339: 459-500.
16. Dequeker J, Westhovens R. Osteoporosis: a matter of concern to rheumatology. Scand J Rheumatol 1995; 24: 130-134.
17. Heath DA. Osteoporosis: current controversies and future trends. Baillière's Clin Rheumatol 1993; 7: 628.
18. Genant HK, Wu CY, Van Kujik C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993; 8: 1.137-1.148.
19. Silman AJ. The patient with fracture: the risk of subsequent fractures. Am J Med 1995; 98 (Supl 2A): 12-16.
20. Riggs BL, Melton LJ III. The prevention and treatment of osteoporosis. N Engl J Med 1992; 327: 620-627.
21. Conference report. Consensus Development Conference: Diagnosis, Prophylaxis and Treatment of Osteoporosis. Am J Med 1993; 94: 646-650.
22. Peel N, Eastell R, Osteoporosis. Br Med J 1995; 310: 989-992.
23. Cardona JM, Seguí J, Siscar C. Calcitonina para el tratamiento de la osteoporosis: su empleo en una zona básica de salud. Aten Primaria 1995; 15: 373-379.
24. d ed.). Nueva York: John Daniel, Wiley and Sons, 1987.
25. a ed.). Nueva York: Wiley and Sons, 1981.
26. Lindsay R. Prevention and treatment of osteoporosis. Lancet 1993; 341: 801-804.
27. Torgerson DJ, Donaldson C, Garton MJ, Russell IT, Westland M, Reid DM. Population screening of low bone mineral density: do non-attenders have a lower risk of osteoporosis. Osteoporos Int 1994; 4: 149-153.
28. Fernández Arias J, Díaz de Torres P, López Rodníguez RM. Influencia de la vía intranasal en el consumo de calcitoninas. Aten Primaria 1995; 15: 211-214.
29. The Multicentre Vertebral Fracture Study Group. Cooper C, Shah S, Hand DJ, Adams J, Compton J, Davie M et al. Screening for vertebral osteoporosis using individual risk factors. Osteoporos Int 1991; 2: 48-53.
30. Spector TD, McCloskey EV, Doyle DV, Kanis JA. Prevalence of vertebral fracture in women and the relationship with bone density and symptoms: the Chingford study. J Bone Min Res 1993; 8: 817-822.
31. Editorial, Vertebral fractures. How large is the silent epidemic? Br Med J 1992; 304: 793-794.
32. Davies KM, Recker RR, Heaney RL. Revisable criteria for vertebral deformity. Osteoporos Int 1993; 3: 265-270.
33. Leidig-Bruckner G, Genant HK, Minne HW, Storm T, Thambsborg G, Bruckner T et al. Comparison of a semiquantitative and a quantitative method for assessing vertebral fractures in osteoporosis. Osteoporos Int 1994; 4: 154-161.
34. Avioli LA. Osteoporosis syndromes: patient selection for calcitonin therapy. Geriatrics 1992; 47: 58-67.
35. Lyles KW, Gold DT, Shipp KM, Pieper CF, Martinez S, Mulhausen PL. Association of osteoporotic vertebral compression fractures with impaired functional status. Am J Med 1993; 94: 595-601.
36. Avioli LA, Calcitonin therapy in osteoporotic syndromes. Rheum Dis Clin North Am 1994; 20: 777-785.
37. Díez Pérez A, Manresa Puig J, Martinez Izquierdo MT, Guelar Grinberg AM, Cucurull Canosa J, Mellibovsky Saldler L et al. Aproximación a los costes de la fractura osteoporótica de fémur en España. Med Clin (Barc) 1992; 98: 441-444.
38. Knobel H, Díez A, Arnau D, Aller A, Ibéñez J, Campodarve Y et al. Secuelas de la fractura osteoporótica de fémur en Barcelona. Med Clin (Barc) 1992; 98: 453-455.